226 related articles for article (PubMed ID: 32636209)
1. In Vitro Human Cell-Based Experimental Models for the Evaluation of Enteric Metabolism and Drug Interaction Potential of Drugs and Natural Products.
Li AP
Drug Metab Dispos; 2020 Oct; 48(10):980-992. PubMed ID: 32636209
[TBL] [Abstract][Full Text] [Related]
2. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.
Loretz C; Ho MD; Alam N; Mitchell W; Li AP
Drug Metab Dispos; 2020 Oct; 48(10):1084-1091. PubMed ID: 32719085
[TBL] [Abstract][Full Text] [Related]
3. Cryopreserved Human Intestinal Mucosal Epithelium: A Novel In Vitro Experimental System for the Evaluation of Enteric Drug Metabolism, Cytochrome P450 Induction, and Enterotoxicity.
Li AP; Alam N; Amaral K; Ho MD; Loretz C; Mitchell W; Yang Q
Drug Metab Dispos; 2018 Nov; 46(11):1562-1571. PubMed ID: 30006371
[TBL] [Abstract][Full Text] [Related]
4. Utility of Pooled Cryopreserved Human Enterocytes as an In vitro Model for Assessing Intestinal Clearance and Drug-Drug Interactions.
Wong S; Doshi U; Vuong P; Liu N; Tay S; Le H; Kosaka M; Kenny JR; Li AP; Yan Z
Drug Metab Lett; 2018; 12(1):3-13. PubMed ID: 29237391
[TBL] [Abstract][Full Text] [Related]
5. A Novel In vitro Experimental System for the Evaluation of Enteric Drug Metabolism: Cofactor-Supplemented Permeabilized Cryopreserved Human Enterocytes (MetMax™ Cryopreserved Human Enterocytes).
Li AP; Amaral K; Ho MD
Drug Metab Lett; 2018; 12(2):132-137. PubMed ID: 30124163
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of In Vitro Models for Assessment of Human Intestinal Metabolism in Drug Discovery.
Davies M; Peramuhendige P; King L; Golding M; Kotian A; Penney M; Shah S; Manevski N
Drug Metab Dispos; 2020 Nov; 48(11):1169-1182. PubMed ID: 32862146
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
[TBL] [Abstract][Full Text] [Related]
8. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.
Suzuki H; Sugiyama Y
Eur J Pharm Sci; 2000 Nov; 12(1):3-12. PubMed ID: 11121729
[TBL] [Abstract][Full Text] [Related]
9. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
[TBL] [Abstract][Full Text] [Related]
10. Human Primary Cell-Based Organotypic Microtissues for Modeling Small Intestinal Drug Absorption.
Ayehunie S; Landry T; Stevens Z; Armento A; Hayden P; Klausner M
Pharm Res; 2018 Feb; 35(4):72. PubMed ID: 29476278
[TBL] [Abstract][Full Text] [Related]
11. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
Wang H; LeCluyse EL
Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
[TBL] [Abstract][Full Text] [Related]
12. Cross-species analysis of hepatic cytochrome P450 and transport protein expression.
Hammer H; Schmidt F; Marx-Stoelting P; Pötz O; Braeuning A
Arch Toxicol; 2021 Jan; 95(1):117-133. PubMed ID: 33150952
[TBL] [Abstract][Full Text] [Related]
13. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.
Li AP; Lu C; Brent JA; Pham C; Fackett A; Ruegg CE; Silber PM
Chem Biol Interact; 1999 Jun; 121(1):17-35. PubMed ID: 10418968
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 Induction and Xeno-Sensing Receptors Pregnane X Receptor, Constitutive Androstane Receptor, Aryl Hydrocarbon Receptor and Peroxisome Proliferator-Activated Receptor α at the Crossroads of Toxicokinetics and Toxicodynamics.
Hakkola J; Bernasconi C; Coecke S; Richert L; Andersson TB; Pelkonen O
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():42-50. PubMed ID: 29527807
[TBL] [Abstract][Full Text] [Related]
15. Coordinate regulation of human drug-metabolizing enzymes, and conjugate transporters by the Ah receptor, pregnane X receptor and constitutive androstane receptor.
Köhle C; Bock KW
Biochem Pharmacol; 2009 Feb; 77(4):689-99. PubMed ID: 18606396
[TBL] [Abstract][Full Text] [Related]
16. Human Enterocytes as an In Vitro Model for the Evaluation of Intestinal Drug Metabolism: Characterization of Drug-Metabolizing Enzyme Activities of Cryopreserved Human Enterocytes from Twenty-Four Donors.
Ho MD; Ring N; Amaral K; Doshi U; Li AP
Drug Metab Dispos; 2017 Jun; 45(6):686-691. PubMed ID: 28396528
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
Rushmore TH; Kong AN
Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes.
Kudo T; Endo Y; Taguchi R; Yatsu M; Ito K
Xenobiotica; 2015 May; 45(5):413-9. PubMed ID: 25470432
[TBL] [Abstract][Full Text] [Related]
19. Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome.
Ohta Y; Kazuki K; Abe S; Oshimura M; Kobayashi K; Kazuki Y
BMC Biotechnol; 2020 Aug; 20(1):44. PubMed ID: 32819341
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans.
Darwich AS; Aslam U; Ashcroft DM; Rostami-Hodjegan A
Drug Metab Dispos; 2014 Dec; 42(12):2016-22. PubMed ID: 25233858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
